Percutaneous etharrol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients

Livraghi, Tito; Bolondi, Luigi; Lazzaroni, Sergio; Marin, Giuseppe; Morabito, Alberto; Ludovico Rapaccini, Gian; Salmi, Andrea; Torzilli, Guido

doi:10.1002/1097-0142(19920215)69:4<925::aid-cncr2820690415>3.0.co;2-g

Public

Percutaneous etharrol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients

Published in Cancer • Feb 15, 1992

Authors:

Tito Livraghi

Luigi Bolondi

Sergio Lazzaroni

Abstract

In 207 cirrhotic patient carriers of hepatocellular carcinoma (HCC), percutaneous ethanol injection (PEI) was administered with ultrasound guidance. The patients were classified as Child's Class A, 136; B, 54; and C, 17. Their mean age was 63.5 years, and the male-female ratio was 3.5:1. There was a...

Subject

Medicine

Hepatocellular carcinoma

Percutaneous ethanol injection

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!